Search for a clinical trial
Other search option(s)
2 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Funded by an IRDiRC member = 
; Member of a ERN = 
National clinical trial(s)
GERMANY
Bayern
MÜNCHEN
PAOLA: A phase III, multicenter, randomized, parallel-group study to assess the efficacy and safety of double-blind Pasireotide LAR 40 mg and Pasireotide LAR 60 mg versus open-label Octreotide LAR or Lanreotide ATG in patients with inadequately controlled Acromegaly - DE - Completed
Medizinische Klinik und Poliklinik IV - Standort Ziemssenstraße
Medizinische Klinik und Poliklinik IV
GERMANY
Bayern
MÜNCHEN